Get the Stockscreener App
2.90
2.47%
0.07
Absci Corp stock is traded at $2.90, with a volume of 4.90M.
It is up +2.47% in the last 24 hours and up +11.97% over the past month.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
See More
Previous Close:
$2.83
Open:
$2.75
24h Volume:
4.90M
Relative Volume:
1.14
Market Cap:
$369.92M
Revenue:
$4.21M
Net Income/Loss:
$-97.67M
P/E Ratio:
-3.1183
EPS:
-0.93
Net Cash Flow:
$-70.76M
1W Performance:
+0.35%
1M Performance:
+11.97%
6M Performance:
-21.83%
1Y Performance:
-28.22%
1-Day Range:
$2.74
$2.92
1-Week Range:
$2.74
$3.20
52-Week Range:
$2.01
$6.33
Absci Corp Stock (ABSI) Company Profile
Name
Absci Corp
Sector
Industry
Phone
(360) 949-1041
Address
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
2.90 | 408.17M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Jan-22-25 | Initiated | Needham | Buy |
| Oct-02-24 | Initiated | Guggenheim | Buy |
| Jul-03-24 | Initiated | Morgan Stanley | Overweight |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-04-23 | Initiated | H.C. Wainwright | Buy |
| Aug-12-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Jul-18-22 | Initiated | Truist | Buy |
| Mar-02-22 | Resumed | Cowen | Market Perform |
| Feb-01-22 | Initiated | Berenberg | Buy |
| Nov-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Aug-16-21 | Initiated | BofA Securities | Neutral |
| Aug-16-21 | Initiated | Cowen | Market Perform |
| Aug-16-21 | Initiated | Credit Suisse | Outperform |
| Aug-16-21 | Initiated | Stifel | Hold |
View All
Absci Corp Stock (ABSI) Latest News
What are analysts’ price targets for Absci Corporation in the next 12 monthsReal Time Tracker For Fast Growth - jammulinksnews.com
Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025 - The Manila Times
Global Antibody Discovery Market to Observe Stupendous Growth at a CAGR of ~10% by 2032 | DelveInsight - GlobeNewswire Inc.
CRSP, ABSI, IRDM: Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Buys Absci and Iridium - MSN
Absci Corporation (NASDAQ:ABSI) Shares Acquired by Royce & Associates LP - MarketBeat
ARK Investment Management LLC Boosts Stock Position in Absci Corporation (NASDAQ:ABSI) - MarketBeat
Morgan Stanley Lowers Absci (NASDAQ:ABSI) Price Target to $6.40 - MarketBeat
Nikko Asset Management Americas Inc. Has $3.74 Million Stock Position in Absci Corporation (NASDAQ:ABSI) - MarketBeat
Absci Corporation Stock (ABSI) Opinions on $50 Million Public Offering - Quiver Quantitative
Absci Corporation Shows Early Signs of Technical StrengthMarket Entry and Exit Point Tips From Traders - metal.it
Cathie Wood Offloads $16.4M of CRISPR Therapeutics Stock, Adds Absci and Iridium - AInvest
Will Absci Corporation Sustain Its Chart BreakoutDaily Volume Spike Trading Signals Detected - metal.it
Absci announces proposed public offering of common stock - MSN
Pier 88 Investment Partners LLC Has $762,000 Stock Holdings in Absci Corporation (NASDAQ:ABSI) - MarketBeat
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics - Benzinga
Cathie Wood’s ARK ETF adjusts portfolio, buys ABSCI, sells CRISPR - Investing.com
Absci Prices $50 Mln Public Offering To Advance AI-Driven Drug Programs - Nasdaq
Absci Announces Public Offering to Raise Capital - TipRanks
Gold Falls Over 1%; Phillips 66 Posts Upbeat Earnings - Benzinga
Absci shares tumble 16% after pricing discounted stock offering - MSN
What analysts say about Absci Corporation stockStrongest growth potential - Autocar Professional
Intel, Absci, and AST SpaceMobile Stocks Move Lower in Friday's Pre-Market Session - AInvest
Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Absci stock falls after pricing public offering below market value - Investing.com
Absci stock dips after pricing $50M offering - MSN
Absci Corporation Stock Analysis and ForecastRecord-breaking gains - PrintWeekIndia
Why Deckers Outdoor Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket - Benzinga
Absci Stock Plunges 14.81% on Public Offering - AInvest
Will Absci Corporation stock benefit from AI tech trendsConsistently high yield - jammulinksnews.com
What drives Absci Corporation stock priceDynamic capital growth - Autocar Professional
Absci prices $50 million public offering of common stock By Investing.com - Investing.com India
Absci prices $50 million public offering of common stock - Investing.com Australia
Absci launches $50 million public offering to fund AI drug programs - Investing.com
Absci's $50M Capital Raise: Strategic Fuel for AI-Driven Drug Discovery - AInvest
Absci's $50 Million Equity Raise: A Strategic Inflection Point for AI-Driven Biopharma? - AInvest
AI Drug Discovery Firm Absci Raises $50M in Public Offering with Morgan Stanley, JP Morgan Leading - Stock Titan
Absci Announces Pricing of Public Offering of Common Stock - FinancialContent
Absci stock falls after announcing $50 million public offering By Investing.com - Investing.com India
Absci stock falls after announcing $50 million public offering - Investing.com Australia
Absci Corporation Initiates $50 Million Underwritten Public Offering of Common Stock - Nasdaq
Absci Announces Proposed Public Offering of Common Stock - GlobeNewswire
AI-Powered Drug Discovery Pioneer Absci Seeks $50M in Fresh Capital for Breakthrough Therapeutics - Stock Titan
What analysts say about Absci Corporation stock outlookExceptional profit velocity - jammulinksnews.com
Absci Corporation's (NASDAQ:ABSI) Recent 13% Pullback Adds to One-year Year Losses, Institutional Owners May Take Drastic Measures - 富途牛牛
Is Absci Corporation a good long term investmentMarket-beating performance - Autocar Professional
Massachusetts Financial Services Co. MA Purchases New Position in Absci Corporation (NASDAQ:ABSI) - MarketBeat
why is ABSI "EPS Beats Expectation" - AInvest
Absci Corp Stock (ABSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):